How Softer Earnings and a Deeper Mastercard Alliance Could Reframe Fiserv’s (FISV) Investment Story

Fiserv, Inc.

Fiserv, Inc.

FISV

0.00

  • In early August 2026, Fiserv reported weaker second-quarter results, with revenue easing to US$5,292 million and net income falling to US$627 million compared with a year earlier, while earnings per share from continuing operations declined to US$1.17.
  • At the same time, Fiserv moved to reshape its business through new partnerships with Mastercard and Stuut Technologies, a joint venture that formed MoneyPass Group, further client wins such as UW Credit Union, and continued share repurchases under its existing buyback plan.
  • Now we’ll examine how Fiserv’s softer earnings alongside the expanded Mastercard partnership may influence the company’s existing investment narrative.

Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Fiserv Investment Narrative Recap

To own Fiserv, you need to believe its broad payments and banking technology platform can compound value despite slower near term progress. The latest quarter’s weaker earnings highlight execution risk and margin pressure as the key near term concerns, while the most important short term catalyst is whether new partnerships and platforms can reaccelerate growth. The recent results make that catalyst less certain, but do not yet fundamentally change the long term narrative.

The expanded global partnership with Mastercard is particularly relevant here, since it directly targets higher value merchant services at a time when revenue and earnings have softened. By integrating Mastercard Merchant Cloud into Commerce Hub, Fiserv is leaning into areas where deeper service penetration and cross sell could matter most for restoring confidence in its earnings power and supporting the thesis that its merchant and software platforms can still be important growth drivers.

Yet investors should be aware that weaker earnings, rising competition, and integration complexity could all weigh more heavily on Fiserv than the headline partnerships suggest...

Fiserv's narrative projects $21.5 billion revenue and $3.4 billion earnings by 2029. This requires revenue to remain fairly flat each year and a $0.6 billion earnings increase from $2.8 billion today.

Uncover how Fiserv's forecasts yield a $62.70 fair value, a 15% upside to its current price.

Exploring Other Perspectives

FISV 1-Year Stock Price Chart
FISV 1-Year Stock Price Chart

Some of the most optimistic analysts expected Fiserv to reach about US$22.5 billion in revenue and US$4.1 billion in earnings by 2029, but with today’s softer results and rising competition from low cost fintechs, you can see how that far more bullish story might need to be revisited compared with a more cautious view that already highlights execution and margin pressure.

Explore 15 other fair value estimates on Fiserv - why the stock might be worth 26% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Fiserv research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Fiserv research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Fiserv's overall financial health at a glance.

No Opportunity In Fiserv?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.